TrialBlood2012

Correlation of CD33 expression level with disease characteristics and response to gemtuzumab ozogamicin containing chemotherapy in childhood AML.

Jessica A Pollard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.